Gilead Sciences Inc. (GILD)
NASDAQ · Healthcare
Gilead Sciences Inc. Income Statement 2007–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenue | 29.44B | 28.75B | 27.12B | 27.28B | 27.30B | 24.69B | 22.45B | 22.13B | 26.11B | 30.39B | 32.64B | 24.89B | 11.20B | 9.70B | 8.39B | 7.95B | 7.01B | 5.34B | 4.23B |
| Gross Profit | 23.21B | 22.50B | 20.62B | 21.62B | 20.70B | 20.12B | 17.77B | 17.27B | 21.74B | 26.13B | 28.63B | 21.10B | 8.34B | 7.23B | 6.26B | 6.08B | 5.42B | 4.21B | 3.46B |
| Profitability | |||||||||||||||||||
| Operating Income | 10.02B | 1.66B | 7.61B | 7.33B | 9.92B | 4.07B | 4.29B | 8.20B | 14.12B | 17.63B | 22.19B | 15.27B | 4.52B | 4.01B | 3.79B | 3.96B | 3.53B | 2.68B | 2.16B |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | 8.51B | 480.0M | 5.67B | 4.59B | 6.22B | 123.0M | 5.39B | 5.46B | 4.63B | 13.50B | 18.11B | 12.10B | 3.08B | 2.59B | 2.80B | 2.90B | 2.64B | 1.98B | 1.58B |
| Per Share Data | |||||||||||||||||||
| EPS (diluted) | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 | $11.91 | $7.35 | $1.81 | $1.64 | $1.77 | $1.66 | $2.82 | $2.06 | $1.64 |
| Shares Outstanding (dil.) | 1,255M | 1,255M | 1,258M | 1,262M | 1,262M | 1,263M | 1,277M | 1,308M | 1,319M | 1,358M | 1,521M | 1,647M | 1,695M | 1,583M | 1,580M | 1,747M | 934M | 959M | 964M |
Gilead Sciences Inc. Income Statement — FAQ
Gilead Sciences Inc. (GILD) income statement over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GILD's income statement history?
The chart and table above show Gilead Sciences Inc.'s income statement by year and by quarter, including the growth rate.